Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Gains from Investment Securities (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Gains from Investment Securities for 11 consecutive years, with $31013.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities fell 99.39% year-over-year to $31013.0, compared with a TTM value of $31013.0 through Sep 2025, down 99.24%, and an annual FY2024 reading of $31013.0, down 66.97% over the prior year.
  • Gains from Investment Securities was $31013.0 for Q3 2025 at Sanara MedTech, down from $3.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $5.1 million in Q3 2024 and bottomed at -$1.2 million in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $725462.1, with a median of $95873.0 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities surged 14574.38% in 2021, then plummeted 370.56% in 2023.
  • Year by year, Gains from Investment Securities stood at $4.4 million in 2021, then plummeted by 105.72% to -$252634.0 in 2022, then tumbled by 370.56% to -$1.2 million in 2023, then surged by 102.61% to $31013.0 in 2024, then changed by 0.0% to $31013.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SMTI at $31013.0 in Q3 2025, $3.3 million in Q2 2025, and $274055.0 in Q1 2025.